Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

FLT1 Antikörper (AA 1048-1328)

FLT1 Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7175380
  • Target Alle FLT1 Antikörper anzeigen
    FLT1 (Fms-Related tyrosine Kinase 1 (VEGFR1) (FLT1))
    Bindungsspezifität
    • 16
    • 12
    • 11
    • 11
    • 7
    • 7
    • 7
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1048-1328
    Reaktivität
    • 143
    • 66
    • 65
    • 12
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 140
    • 32
    • 3
    • 1
    Kaninchen
    Klonalität
    • 141
    • 35
    Polyklonal
    Konjugat
    • 92
    • 22
    • 11
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser FLT1 Antikörper ist unkonjugiert
    Applikation
    • 111
    • 48
    • 43
    • 36
    • 23
    • 22
    • 21
    • 15
    • 14
    • 13
    • 8
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Vascular endothelial growth factor receptor 1 protein (1048-1328AA)
    Isotyp
    IgG
    Top Product
    Discover our top product FLT1 Primärantikörper
  • Applikationshinweise
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    FLT1 (Fms-Related tyrosine Kinase 1 (VEGFR1) (FLT1))
    Andere Bezeichnung
    FLT1 (FLT1 Produkte)
    Synonyme
    FLT antikoerper, FLT-1 antikoerper, VEGFR-1 antikoerper, VEGFR1 antikoerper, FLT1 antikoerper, flt1b antikoerper, sFlt1 antikoerper, AI323757 antikoerper, Flt-1 antikoerper, fms related tyrosine kinase 1 antikoerper, FMS-related tyrosine kinase 1 antikoerper, vascular endothelial growth factor receptor 1 antikoerper, fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) antikoerper, FMS-like tyrosine kinase 1 antikoerper, vascular endothelial growth factor receptor-1 antikoerper, FLT1 antikoerper, Flt1 antikoerper, CpipJ_CPIJ012087 antikoerper, flt1 antikoerper, FLT-1 antikoerper
    Hintergrund

    Background: Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. May play an essential role as a negative regulator of embryonic angiogenesis by inhibiting excessive proliferation of endothelial cells. Can promote endothelial cell proliferation, survival and angiogenesis in adulthood. Its function in promoting cell proliferation seems to be cell-type specific. Promotes PGF-mediated proliferation of endothelial cells, proliferation of some types of cancer cells, but does not promote proliferation of normal fibroblasts (in vitro). Has very high affinity for VEGFA and relatively low protein kinase activity, may function as a negative regulator of VEGFA signaling by limiting the amount of free VEGFA and preventing its binding to KDR. Likewise, isoforms lacking a transmembrane domain, such as isoform 2, isoform 3 and isoform 4, may function as decoy receptors for VEGFA. Modulates KDR signaling by forming heterodimers with KDR. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate and the activation of protein kinase C. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leading to activation of phosphatidylinositol kinase and the downstream signaling pathway. Mediates activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Phosphorylates SRC and YES1, and may also phosphorylate CBL. Isoform 1 phosphorylates PLCG. Promotes phosphorylation of AKT1 at \\\'Ser-473\\\'. Promotes phosphorylation of PTK2/FAK1. Isoform 7 has a truncated kinase domain, it increases phosphorylation of SRC at \\\'Tyr-418\\\' by unknown means and promotes tumor cell invasion.

    Aliases: EC 2.7.10.1 antibody, FLT 1 antibody, FLT antibody, Flt-1 antibody, FLT1 antibody, Fms like tyrosine kinase 1 antibody, Fms related tyrosine kinase 1 antibody, Fms related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) antibody, Fms related tyrosine kinase 1 vascular endothelial growth factor/vascular permeability factor receptor antibody, Fms-like tyrosine kinase 1 antibody, FRT antibody, Soluble VEGF receptor 1 14 antibody, Soluble VEGFR1 variant 2 antibody, Soluble VEGFR1 variant 21 antibody, Tyrosine protein kinase FRT antibody, Tyrosine protein kinase receptor FLT antibody, Tyrosine-protein kinase FRT antibody, Tyrosine-protein kinase receptor FLT antibody, Vascular endothelial growth factor receptor 1 antibody, Vascular endothelial growth factor vascular permeability factor receptor antibody, Vascular permeability factor receptor 1 antibody, Vascular permeability factor receptor antibody, VEGFR 1 antibody, VEGFR-1 antibody, VEGFR1 antibody, VGFR1_HUMAN antibody

    UniProt
    P17948
    Pathways
    RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Sie sind hier: